My Bibliography

select

Gensheimer J, LaGosh J, Moulton ER, Sun V, de Barros SC, Montecino-Rodriguez E, Yiu G, Yuan X, Dorshkind K, Crooks GM. Clonal Analyses Reveal the Impact of Hematopoietic Stem and Progenitor Cell Aging on T Cell Development. Aging Cell. 2026 Jul;25(7):e70615. doi: 10.1111/acel.70615. PubMed PMID: 42374656; PubMed Central PMCID: PMC13314711.

select

Bernard MJ, Gallardo A, Ruiz A, Diaz JA, Nunley NM, Dove RN, Zhang S, Lee E, Heering KY, Varuzhanyan G, Bopardikar S, Hashimoto T, Agrawal R, Smith CM, Wilde BR, Matulionis N, Richards HM, Lee SCS, Sharifi MN, Lang JM, Zhao SG, Witte ON, Haffner MC, Shackelford DB, Boutros PC, Christofk HR, Goldstein AS. OGDHL Promotes Prostate Cancer Progression and Regulates Neuroendocrine Marker Expression and Nucleotide Abundance. Mol Cancer Res. 2026 May 4;24(5):356-375. doi: 10.1158/1541-7786.MCR-25-0913. PubMed PMID: 41591383; PubMed Central PMCID: PMC12949684.

select

Patel Y, Zhu C, Yamaguchi TN, Wang NK, Wiltsie N, Zeltser N, Gonzalez AE, Winata HK, Pan Y, Mootor MFE, Sanders T, Fitz-Gibbon ST, Kandoth C, Livingstone J, Liu LY, Carlin B, Holmes A, Oh J, Sahrmann J, Tao S, Eng S, Hugh-White R, Pashminehazar K, Beshlikyan A, Jordan M, Wu S, Tian M, Arbet J, Neilsen B, Haas R, Bugh YZ, Kim G, Salmingo J, Zhang W, Anand A, Hwang E, Neiman-Golden A, Steinberg P, Zhao W, Anand P, Agrawal R, Tsai BL, Boutros PC. Metapipeline-DNA: A comprehensive germline and somatic genomics Nextflow pipeline. Cell Rep Methods. 2026 Mar 23;6(3):101340. doi: 10.1016/j.crmeth.2026.101340. Epub 2026 Mar 17. PubMed PMID: 41850291; PubMed Central PMCID: PMC13030954.

select

Baker TM, Matulionis N, Andrasz C, Gerke D, Garcia-Dutton N, Atkinson D, Chiotti K, Wu S, Lulla S, Oh J, Winata H, Huang RR, Lester J, Karlan BY, Spellman PT. Genome-wide classification of tumor-derived reads from bulk long-read sequencing. bioRxiv. 2026 Mar 5;. doi: 10.64898/2026.03.03.709085. PubMed PMID: 41846971; PubMed Central PMCID: PMC12991090.

select

Baisiwala S, Fazzari E, Li MX, Martija A, Azizad DJ, Sun L, Herrera G, Phan T, Monteleone A, Kan RL, Nathanson DA, Wang AC, Kim W, Everson RG, Patel KS, Liau LM, Prins RM, Bhaduri A. A human tumor-immune organoid model of glioblastoma. Cell Rep. 2026 Jan 27;45(1):116790. doi: 10.1016/j.celrep.2025.116790. Epub 2026 Jan 7. PubMed PMID: 41505256; PubMed Central PMCID: PMC12969483.

select

Cho NS, Le VL, Teraishi A, Liu V, Sanvito F, Telesca D, Nakajo M, Wang C, Oshima S, Eldred BSC, Yao J, Nghiemphu PL, Salamon N, Cloughesy TF, Lai A, Ellingson BM. Perfusion, diffusion, and anatomical MRI characteristics of pathologically confirmed malignant transformation in IDH-mutant gliomas. Neuro Oncol. 2025 Dec 1;27(12):3306-3317. doi: 10.1093/neuonc/noaf171. PubMed PMID: 40888039; PubMed Central PMCID: PMC12916721.

select

Sanvito F, Kim A, Raymond C, Teraishi A, Everson RG, Nghiemphu PL, Lai A, Chong RA, Nathanson DA, Salamon N, Cloughesy TF, Yao J, Ellingson BM. Impact of corticosteroid administration on contrast-enhancing volume and diffusion MRI in treatment naïve glioblastoma. Neuro Oncol. 2025 Nov 1;27(11):3016-3026. doi: 10.1093/neuonc/noaf136. PubMed PMID: 40443040; PubMed Central PMCID: PMC12908483.

select

de la Fuente MI, Touat M, van den Bent MJ, Preusser M, Peters KB, Young RJ, Huang RY, Ellingson BM, Capper D, Phillips JJ, Halasz LM, Shih HA, Rudà R, Lim-Fat MJ, Blumenthal DT, Weller M, Arakawa Y, Whittle JR, Ducray F, Reardon DA, Bi WL, Minniti G, Rahman R, Hervey-Jumper S, Chang SM, Wen PY. The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant glioma. Neuro Oncol. 2025 Jun 21;27(5):1135-1148. doi: 10.1093/neuonc/noae259. Review. PubMed PMID: 39723472; PubMed Central PMCID: PMC12187374.

select

Wu S, Pathak GA, Chen Z. Toward equitable biomarkers of aging: rethinking methylation clocks. Trends Genet. 2025 Jul;41(7):552-553. doi: 10.1016/j.tig.2025.06.001. Epub 2025 Jun 18. PubMed PMID: 40533324; PubMed Central PMCID: PMC12221226.

select

Leak L, Wang Z, Joseph AJ, Johnson B, Chan AA, Decosto CM, Magtanong L, Ko PJ, Lee WC, Ritho J, Manukian S, Millner A, Chitkara S, Salinas JJ, Skouta R, Rees MG, Ronan MM, Roth JA, Myers CL, Moffat J, Boone C, Bensinger SJ, Nathanson DA, Atilla-Gokcumen GE, Moding EJ, Dixon SJ. Tegavivint triggers TECR-dependent nonapoptotic cancer cell death. Nat Chem Biol. 2025 Dec;21(12):1873-1884. doi: 10.1038/s41589-025-01913-4. Epub 2025 May 26. PubMed PMID: 40419770; PubMed Central PMCID: PMC13119621.

select

Patel Y, Zhu C, Yamaguchi TN, Wang NK, Wiltsie N, Zeltser N, Gonzalez AE, Winata HK, Pan Y, Mootor MFE, Sanders T, Fitz-Gibbon ST, Kandoth C, Livingstone J, Liu LY, Carlin B, Holmes A, Oh J, Sahrmann J, Tao S, Eng S, Hugh-White R, Pashminehazar K, Park A, Beshlikyan A, Jordan M, Wu S, Tian M, Arbet J, Neilsen B, Haas R, Bugh YZ, Kim G, Salmingo J, Zhang W, Anand A, Hwang E, Neiman-Golden A, Steinberg P, Zhao W, Anand P, Agrawal R, Tsai BL, Boutros PC. Metapipeline-DNA: A Comprehensive Germline & Somatic Genomics Nextflow Pipeline. bioRxiv. 2025 Apr 25;. doi: 10.1101/2024.09.04.611267. PubMed PMID: 39282325; PubMed Central PMCID: PMC11398472.

select

Lopez Kolkovsky AL, Wang C, Yao J, Ellingson BM. Multinuclear Interleaving of (1)H CEST, Water T(2)*, and (23)Na MRI at 3 T. NMR Biomed. 2025 Mar;38(3):e70003. doi: 10.1002/nbm.70003. PubMed PMID: 39948226; PubMed Central PMCID: PMC11825412.

select

Sanvito F, Yao J, Cho NS, Raymond C, Telesca D, Pope WB, Everson RG, Salamon N, Boxerman JL, Cloughesy TF, Ellingson BM. "Synthetic" DSC Perfusion MRI with Adjustable Acquisition Parameters in Brain Tumors Using Dynamic Spin-and-Gradient-Echo Echoplanar Imaging. AJNR Am J Neuroradiol. 2025 Feb 3;46(2):311-320. doi: 10.3174/ajnr.A8475. PubMed PMID: 39242197; PubMed Central PMCID: PMC11878977.

select

Jones AE, Rios A, Ibrahimovic N, Chavez C, Bayley NA, Ball AB, Hsieh WY, Sammarco A, Bianchi AR, Cortez AA, Graeber TG, Hoffmann A, Bensinger SJ, Divakaruni AS. The metabolic cofactor Coenzyme A enhances alternative macrophage activation via MyD88-linked signaling. bioRxiv. 2025 Jan 20;. doi: 10.1101/2024.03.28.587096. PubMed PMID: 38585887; PubMed Central PMCID: PMC10996702.

select

Clutario KM, Abdusamad M, Ramirez I, Rich KJ, Gholkar AA, Zaragoza J, Torres JZ. Human REXO4 is Required for Cell Cycle Progression. bioRxiv. 2025 Jan 9;. doi: 10.1101/2025.01.08.631954. PubMed PMID: 39829749; PubMed Central PMCID: PMC11741406.

select

Ellingson BM, Sanvito F, Pope WB, Cloughesy TF, Huang RY, Villanueva-Meyer JE, Barboriak DP, Shankar LK, Smits M, Kaufmann TJ, Boxerman JL, Weller M, Galanis E, Groot J, Chang SM, Gilbert MR, Lassman AB, Shiroishi MS, Nabavizadeh A, Mehta M, Stupp R, Wick W, Reardon DA, Wen PY, Vogelbaum MA, van den Bent M. Reply. AJNR Am J Neuroradiol. 2025 Jan 8;46(1):221-222. doi: 10.3174/ajnr.A8621. PubMed PMID: 39730160; PubMed Central PMCID: PMC11735428.

select

Ball AB, Jones AE, Nguyễn KB, Rios A, Marx N, Hsieh WY, Yang K, Desousa BR, Kim KKO, Veliova M, Del Mundo ZM, Shirihai OS, Benincá C, Stiles L, Bensinger SJ, Divakaruni AS. Pro-inflammatory macrophage activation does not require inhibition of oxidative phosphorylation. EMBO Rep. 2025 Feb;26(4):982-1002. doi: 10.1038/s44319-024-00351-y. Epub 2025 Jan 3. PubMed PMID: 39753784; PubMed Central PMCID: PMC11850891.

select

Ellingson BM, Sanvito F, Cloughesy TF, Huang RY, Villanueva-Meyer JE, Pope WB, Barboriak DP, Shankar LK, Smits M, Kaufmann TJ, Boxerman JL, Weller M, Galanis E, Groot J, Gilbert MR, Lassman AB, Shiroishi MS, Nabavizadeh A, Mehta M, Stupp R, Wick W, Reardon DA, Vogelbaum MA, van den Bent M, Chang SM, Wen PY. A Neuroradiologist's Guide to Operationalizing the Response Assessment in Neuro-Oncology (RANO) Criteria Version 2.0 for Gliomas in Adults. AJNR Am J Neuroradiol. 2024 Dec 9;45(12):1846-1856. doi: 10.3174/ajnr.A8396. Review. PubMed PMID: 38926092; PubMed Central PMCID: PMC11630866.

select

Le Rhun E, Albert NL, Hüllner M, Franceschi E, Galldiks N, Karschnia P, Minniti G, Weiss T, Preusser M, Ellingson BM, Weller M. Targeted radionuclide therapy for patients with central nervous system metastasis: Overlooked potential?. Neuro Oncol. 2024 Dec 9;26(Supplement_9):S229-S241. doi: 10.1093/neuonc/noae192. Review. PubMed PMID: 39351771; PubMed Central PMCID: PMC11631097.

select

Sarkaria JN, Ballman KV, Kizilbash SH, Sulman EP, Giannini C, Friday BB, Butowski NA, Mohile NA, Piccioni DE, Battiste JD, Drappatz J, Campian JL, Mashru S, Jaeckle KA, O'Brien BJ, Dixon JG, Kabat BF, Laack NL, Hu LS, Kaufmann T, Kumthekar P, Ellingson BM, Anderson SK, Galanis E. Efficacy of Adding Veliparib to Temozolomide for Patients With MGMT-Methylated Glioblastoma: A Randomized Clinical Trial. JAMA Oncol. 2024 Dec 1;10(12):1637-1644. doi: 10.1001/jamaoncol.2024.4361. PubMed PMID: 39480453; PubMed Central PMCID: PMC11528341.

select

Shiroishi MS, Erickson BJ, Hu LS, Barboriak DP, Becerra L, Bell LC, Boss MA, Boxerman JL, Cen S, Cimino L, Fan Z, Keenan KE, Kirsch JE, Ameli N, Nazemi S, Quarles CC, Rosen MA, Rodriguez L, Schmainda KM, Zahlmann G, Zhou Y, Obuchowski N, Wu O, RSNA QIBA Dynamic Susceptibility Contrast MRI Biomarker Committee. The QIBA Profile for Dynamic Susceptibility Contrast MRI Quantitative Imaging Biomarkers for Assessing Gliomas. Radiology. 2024 Dec;313(3):e232555. doi: 10.1148/radiol.232555. Review. PubMed PMID: 39656118; PubMed Central PMCID: PMC11694077.

select

Varuzhanyan G, Chen CC, Freeland J, He T, Tran W, Song K, Wang L, Cheng D, Xu S, Dibernardo GA, Esedebe FN, Bhatia V, Han M, Abt ER, Park JW, Memarzadeh S, Shackelford DB, Lee JK, Graeber TG, Shirihai OS, Witte ON. PGC-1α drives small cell neuroendocrine cancer progression toward an ASCL1-expressing subtype with increased mitochondrial capacity. Proc Natl Acad Sci U S A. 2024 Dec 3;121(49):e2416882121. doi: 10.1073/pnas.2416882121. Epub 2024 Nov 26. PubMed PMID: 39589879; PubMed Central PMCID: PMC11626175.

select

Fernandez EG, Mai WX, Song K, Bayley NA, Kim J, Zhu H, Pioso M, Young P, Andrasz CL, Cadet D, Liau LM, Li G, Yong WH, Rodriguez FJ, Dixon SJ, Souers AJ, Li JJ, Graeber TG, Cloughesy TF, Nathanson DA. Integrated molecular and functional characterization of the intrinsic apoptotic machinery identifies therapeutic vulnerabilities in glioma. Nat Commun. 2024 Nov 21;15(1):10089. doi: 10.1038/s41467-024-54138-9. PubMed PMID: 39572533; PubMed Central PMCID: PMC11582606.

select

Cho NS, Sanvito F, Le VL, Oshima S, Teraishi A, Yao J, Telesca D, Raymond C, Pope WB, Nghiemphu PL, Lai A, Salamon N, Cloughesy TF, Ellingson BM. Diffusion MRI is superior to quantitative T2-FLAIR mismatch in predicting molecular subtypes of human non-enhancing gliomas. Neuroradiology. 2024 Dec;66(12):2153-2162. doi: 10.1007/s00234-024-03475-z. Epub 2024 Oct 8. PubMed PMID: 39377927; PubMed Central PMCID: PMC11611930.

select

Cho NS, Wang C, Van Dyk K, Sanvito F, Oshima S, Yao J, Lai A, Salamon N, Cloughesy TF, Nghiemphu PL, Ellingson BM. Pseudo-Resting-State Functional MRI Derived from Dynamic Susceptibility Contrast Perfusion MRI Can Predict Cognitive Impairment in Glioma. AJNR Am J Neuroradiol. 2024 Oct 3;45(10):1552-1561. doi: 10.3174/ajnr.A8327. PubMed PMID: 38719607; PubMed Central PMCID: PMC11448991.

select

Cho NS, Le VL, Sanvito F, Oshima S, Harper J, Chun S, Raymond C, Lai A, Nghiemphu PL, Yao J, Everson R, Salamon N, Cloughesy TF, Ellingson BM. Digital "flipbooks" for enhanced visual assessment of simple and complex brain tumors. Neuro Oncol. 2024 Oct 3;26(10):1823-1836. doi: 10.1093/neuonc/noae097. PubMed PMID: 38808755; PubMed Central PMCID: PMC11449060.

select

van den Bent MJ, French PJ, Brat D, Tonn JC, Touat M, Ellingson BM, Young RJ, Pallud J, von Deimling A, Sahm F, Figarella Branger D, Huang RY, Weller M, Mellinghoff IK, Cloughsey TF, Huse JT, Aldape K, Reifenberger G, Youssef G, Karschnia P, Noushmehr H, Peters KB, Ducray F, Preusser M, Wen PY. The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?. Neuro Oncol. 2024 Oct 3;26(10):1805-1822. doi: 10.1093/neuonc/noae107. Review. PubMed PMID: 38912846; PubMed Central PMCID: PMC11449017.

select

Ayoub PG, Gensheimer J, Lathrop L, Juett C, Quintos J, Tam K, Reid J, Ma F, Tam C, McAuley GE, Brown D, Wu X, Zhang R, Bradford K, Hollis RP, Crooks GM, Kohn DB. Lentiviral vectors for precise expression to treat X-linked lymphoproliferative disease. Mol Ther Methods Clin Dev. 2024 Dec 12;32(4):101323. doi: 10.1016/j.omtm.2024.101323. eCollection 2024 Dec 12. PubMed PMID: 39309261; PubMed Central PMCID: PMC11415656.

select

Varuzhanyan G, Chen CC, Freeland J, He T, Tran W, Song K, Wang L, Cheng D, Xu S, Dibernardo GA, Esedebe FN, Bhatia V, Han M, Abt ER, Park JW, Memarzadeh S, Shackelford D, Lee JK, Graeber T, Shirihai O, Witte O. PGC-1α drives small cell neuroendocrine cancer progression towards an ASCL1-expressing subtype with increased mitochondrial capacity. bioRxiv. 2024 Jul 25;. doi: 10.1101/2024.04.09.588489. PubMed PMID: 38645232; PubMed Central PMCID: PMC11030384.

select

Sanvito F, Castellano A, Cloughesy TF, Wen PY, Ellingson BM. RANO 2.0 criteria: concepts applicable to the neuroradiologist's clinical practice. Curr Opin Oncol. 2024 Nov 1;36(6):536-544. doi: 10.1097/CCO.0000000000001077. Epub 2024 Jul 23. Review. PubMed PMID: 39011735; PubMed Central PMCID: PMC11493521.

select

Ghezzi C, Ellingson BM, Lai A, Liu J, Barrio JR, Wright EM. Effect of Jardiance on glucose uptake into astrocytomas. J Neurooncol. 2024 Sep;169(2):437-444. doi: 10.1007/s11060-024-04746-8. Epub 2024 Jul 22. PubMed PMID: 39037688; PubMed Central PMCID: PMC11341586.

select

Goins LM, Girard JR, Mondal BC, Buran S, Su CC, Tang R, Biswas T, Kissi JA, Banerjee U. Wnt signaling couples G2 phase control with differentiation during hematopoiesis in Drosophila. Dev Cell. 2024 Sep 23;59(18):2477-2496.e5. doi: 10.1016/j.devcel.2024.05.023. Epub 2024 Jun 11. PubMed PMID: 38866012; PubMed Central PMCID: PMC11421984.

select

Schreck KC, Strowd RE, Nabors LB, Ellingson BM, Chang M, Tan SK, Abdullaev Z, Turakulov R, Aldape K, Danda N, Desideri S, Fisher J, Iacoboni M, Surakus T, Rudek MA, Bettegowda C, Grossman SA, Ye X. Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma. Clin Cancer Res. 2024 May 15;30(10):2048-2056. doi: 10.1158/1078-0432.CCR-23-3241. PubMed PMID: 38446982; PubMed Central PMCID: PMC11096001.

select

Everson RG, Hugo W, Sun L, Antonios J, Lee A, Ding L, Bu M, Khattab S, Chavez C, Billingslea-Yoon E, Salazar A, Ellingson BM, Cloughesy TF, Liau LM, Prins RM. TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in malignant glioma: a randomized phase II Trial. Nat Commun. 2024 May 8;15(1):3882. doi: 10.1038/s41467-024-48073-y. PubMed PMID: 38719809; PubMed Central PMCID: PMC11078958.

select

Cho NS, Sanvito F, Le VL, Oshima S, Teraishi A, Yao J, Telesca D, Raymond C, Pope WB, Nghiemphu PL, Lai A, Cloughesy TF, Salamon N, Ellingson BM. Quantification of T2-FLAIR Mismatch in Nonenhancing Diffuse Gliomas Using Digital Subtraction. AJNR Am J Neuroradiol. 2024 Feb 7;45(2):188-197. doi: 10.3174/ajnr.A8094. PubMed PMID: 38238098; PubMed Central PMCID: PMC11285991.

select

Patel KS, Yao J, Cho NS, Sanvito F, Tessema K, Alvarado A, Dudley L, Rodriguez F, Everson R, Cloughesy TF, Salamon N, Liau LM, Kornblum HI, Ellingson BM. pH-Weighted amine chemical exchange saturation transfer echo planar imaging visualizes infiltrating glioblastoma cells. Neuro Oncol. 2024 Jan 5;26(1):115-126. doi: 10.1093/neuonc/noad150. PubMed PMID: 37591790; PubMed Central PMCID: PMC10768991.

select

Albert NL, Galldiks N, Ellingson BM, van den Bent MJ, Chang SM, Cicone F, de Groot J, Koh ES, Law I, Le Rhun E, Mair MJ, Minniti G, Rudà R, Scott AM, Short SC, Smits M, Suchorska B, Tolboom N, Traub-Weidinger T, Tonn JC, Verger A, Weller M, Wen PY, Preusser M. PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group. Lancet Oncol. 2024 Jan;25(1):e29-e41. doi: 10.1016/S1470-2045(23)00525-9. Review. PubMed PMID: 38181810; PubMed Central PMCID: PMC11787868.

select

Zapanta Rinonos S, Li T, Pianka ST, Prins TJ, Eldred BSC, Kevan BM, Liau LM, Nghiemphu PL, Cloughesy TF, Lai A. dCas9/CRISPR-based methylation of O-6-methylguanine-DNA methyltransferase enhances chemosensitivity to temozolomide in malignant glioma. J Neurooncol. 2024 Jan;166(1):129-142. doi: 10.1007/s11060-023-04531-z. Epub 2024 Jan 15. PubMed PMID: 38224404; PubMed Central PMCID: PMC10824881.

select

Chen CC, Tran W, Song K, Sugimoto T, Obusan MB, Wang L, Sheu KM, Cheng D, Ta L, Varuzhanyan G, Huang A, Xu R, Zeng Y, Borujerdpur A, Bayley NA, Noguchi M, Mao Z, Morrissey C, Corey E, Nelson PS, Zhao Y, Huang J, Park JW, Witte ON, Graeber TG. Temporal evolution reveals bifurcated lineages in aggressive neuroendocrine small cell prostate cancer trans-differentiation. Cancer Cell. 2023 Dec 11;41(12):2066-2082.e9. doi: 10.1016/j.ccell.2023.10.009. Epub 2023 Nov 22. PubMed PMID: 37995683; PubMed Central PMCID: PMC10878415.

select

Wang CW, Clémot M, Hashimoto T, Diaz JA, Goins LM, Goldstein AS, Nagaraj R, Banerjee U. A conserved mechanism for JNK-mediated loss of Notch function in advanced prostate cancer. Sci Signal. 2023 Nov 7;16(810):eabo5213. doi: 10.1126/scisignal.abo5213. Epub 2023 Nov 7. PubMed PMID: 37934809; PubMed Central PMCID: PMC10802904.

select

Venneti S, Kawakibi AR, Ji S, Waszak SM, Sweha SR, Mota M, Pun M, Deogharkar A, Chung C, Tarapore RS, Ramage S, Chi A, Wen PY, Arrillaga-Romany I, Batchelor TT, Butowski NA, Sumrall A, Shonka N, Harrison RA, de Groot J, Mehta M, Hall MD, Daghistani D, Cloughesy TF, Ellingson BM, Beccaria K, Varlet P, Kim MM, Umemura Y, Garton H, Franson A, Schwartz J, Jain R, Kachman M, Baum H, Burant CF, Mottl SL, Cartaxo RT, John V, Messinger D, Qin T, Peterson E, Sajjakulnukit P, Ravi K, Waugh A, Walling D, Ding Y, Xia Z, Schwendeman A, Hawes D, Yang F, Judkins AR, Wahl D, Lyssiotis CA, de la Nava D, Alonso MM, Eze A, Spitzer J, Schmidt SV, Duchatel RJ, Dun MD, Cain JE, Jiang L, Stopka SA, Baquer G, Regan MS, Filbin MG, Agar NYR, Zhao L, Kumar-Sinha C, Mody R, Chinnaiyan A, Kurokawa R, Pratt D, Yadav VN, Grill J, Kline C, Mueller S, Resnick A, Nazarian J, Allen JE, Odia Y, Gardner SL, Koschmann C. Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways. Cancer Discov. 2023 Nov 1;13(11):2370-2393. doi: 10.1158/2159-8290.CD-23-0131. PubMed PMID: 37584601; PubMed Central PMCID: PMC10618742.

select

Karschnia P, Smits M, Reifenberger G, Le Rhun E, Ellingson BM, Galldiks N, Kim MM, Huse JT, Schnell O, Harter PN, Mohme M, Expert Rater Panel, von Baumgarten L, Albert NL, Huang RY, Mehta MP, van den Bent M, Weller M, Vogelbaum MA, Chang SM, Berger MS, Tonn JC. A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups. Lancet Oncol. 2023 Nov;24(11):e438-e450. doi: 10.1016/S1470-2045(23)00453-9. Review. PubMed PMID: 37922934; PubMed Central PMCID: PMC10849105.

select

Sanvito F, Raymond C, Cho NS, Yao J, Hagiwara A, Orpilla J, Liau LM, Everson RG, Nghiemphu PL, Lai A, Prins R, Salamon N, Cloughesy TF, Ellingson BM. Simultaneous quantification of perfusion, permeability, and leakage effects in brain gliomas using dynamic spin-and-gradient-echo echoplanar imaging MRI. Eur Radiol. 2024 May;34(5):3087-3101. doi: 10.1007/s00330-023-10215-z. Epub 2023 Oct 26. PubMed PMID: 37882836; PubMed Central PMCID: PMC11045669.

select

Ellingson BM, Hagiwara A, Morris CJ, Cho NS, Oshima S, Sanvito F, Oughourlian TC, Telesca D, Raymond C, Abrey LE, Garcia J, Aftab DT, Hessel C, Rachmilewitz Minei T, Harats D, Nathanson DA, Wen PY, Cloughesy TF. Depth of Radiographic Response and Time to Tumor Regrowth Predicts Overall Survival Following Anti-VEGF Therapy in Recurrent Glioblastoma. Clin Cancer Res. 2023 Oct 13;29(20):4186-4195. doi: 10.1158/1078-0432.CCR-23-1235. PubMed PMID: 37540556; PubMed Central PMCID: PMC10592195.

select

Strowd R, Ellingson B, Raymond C, Yao J, Wen PY, Ahluwalia M, Piotrowski A, Desai A, Clarke JL, Lieberman FS, Desideri S, Nabors LB, Ye X, Grossman S. Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastoma. J Neurooncol. 2023 Oct;165(1):101-112. doi: 10.1007/s11060-023-04456-7. Epub 2023 Oct 21. PubMed PMID: 37864646; PubMed Central PMCID: PMC10863646.

select

Wen PY, van den Bent M, Youssef G, Cloughesy TF, Ellingson BM, Weller M, Galanis E, Barboriak DP, de Groot J, Gilbert MR, Huang R, Lassman AB, Mehta M, Molinaro AM, Preusser M, Rahman R, Shankar LK, Stupp R, Villanueva-Meyer JE, Wick W, Macdonald DR, Reardon DA, Vogelbaum MA, Chang SM. RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults. J Clin Oncol. 2023 Nov 20;41(33):5187-5199. doi: 10.1200/JCO.23.01059. Epub 2023 Sep 29. PubMed PMID: 37774317; PubMed Central PMCID: PMC10860967.

select

Everson RG, Hugo W, Sun L, Antonios J, Lee A, Ding L, Bu M, Khattab S, Chavez C, Billingslea-Yoon E, Salazar A, Ellingson BM, Cloughesy TF, Liau LM, Prins RM. Dendritic Cell Vaccination in Conjunction with a TLR Agonist Polarizes Interferon Immune Responses in Malignant Glioma Patients. Res Sq. 2023 Sep 12;. doi: 10.21203/rs.3.rs-3287211/v1. PubMed PMID: 37790490; PubMed Central PMCID: PMC10543402.

select

Kurokawa R, Hagiwara A, Kurokawa M, Ellingson BM, Baba A, Moritani T. Diffusion histogram profiles predict molecular features of grade 4 in histologically lower-grade adult diffuse gliomas following WHO classification 2021. Eur Radiol. 2024 Feb;34(2):1367-1375. doi: 10.1007/s00330-023-10071-x. Epub 2023 Aug 15. PubMed PMID: 37581661; PubMed Central PMCID: PMC10853353.

select

Sanvito F, Telesca D, Cho NS, Sayari JT, Nagaraj R, Raymond C, Rana S, Patel K, Mozaffari K, Unterberger AA, Khanlou N, Magaki S, Pouratian N, Everson RG, Yang I, Kim W, Ellingson BM. Small pretreatment lesion size and high sphericity as favorable prognostic factors after laser interstitial thermal therapy in brain metastases. J Neurosurg. 2024 Feb 1;140(2):338-349. doi: 10.3171/2023.5.JNS23285. Print 2024 Feb 1. PubMed PMID: 37542437; PubMed Central PMCID: PMC11787867.

select

Kim MM, Mehta MP, Smart DK, Steeg PS, Hong JA, Espey MG, Prasanna PG, Crandon L, Hodgdon C, Kozak N, Armstrong TS, Morikawa A, Willmarth N, Tanner K, Boire A, Gephart MH, Margolin KA, Hattangadi-Gluth J, Tawbi H, Trifiletti DM, Chung C, Basu-Roy U, Burns R, Oliva ICG, Aizer AA, Anders CK, Davis J, Ahluwalia MS, Chiang V, Li J, Kotecha R, Formenti SC, Ellingson BM, Gondi V, Sperduto PW, Barnholtz-Sloan JS, Rodon J, Lee EQ, Khasraw M, Yeboa DN, Brastianos PK, Galanis E, Coleman CN, Ahmed MM. National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities. Lancet Oncol. 2023 Aug;24(8):e344-e354. doi: 10.1016/S1470-2045(23)00297-8. Review. PubMed PMID: 37541280; PubMed Central PMCID: PMC10681121.